AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Temsirolimus'
:
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Publication Year: 2007
DOI: https://doi.org/10.1056/nejmoa066838
Abstract:
Add to Library
Authors:
Gary R. Hudes
Michael A. Carducci
Piotr Tomczak
J. P. Dutcher
Robert A. Figlin
Anil Kapoor
Elżbieta Starosławska
Jeffrey A. Sosman
Damian A. Laber
I. Bodrogi
Zoran Kovačević
Vladimir Lesovoy
Amit Sharma
О. Л. Барбараш
Erhan Gökmen
Timothy E. O’Toole
Stephanie Lustgarten
Laurence Moore
Robert J. Motzer
Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
Publication Year: 2005
DOI: https://doi.org/10.1200/jco.2005.23.622
Abstract:
Add to Library
Authors:
Evanthia Galanis
Jan C. Buckner
Matthew J. Maurer
Jeffrey I. Kreisberg
Karla V. Ballman
Joseph Boni
Josep Maria Peralba
Robert B. Jenkins
Shaker R. Dakhil
Roscoe F. Morton
Kurt A. Jaeckle
Bernd W. Scheithauer
Janet Dancey
Manuel Hidalgo
Daniel J. Walsh
Antiangiogenic Potential of the Mammalian Target of Rapamycin Inhibitor Temsirolimus
Publication Year: 2006
DOI: https://doi.org/10.1158/0008-5472.can-05-2825
Abstract:
Add to Library
Authors:
Donatella Del Bufalo
Ludovica Ciuffreda
Daniela Trisciuoglio
Marianna Desideri
F. Cognetti
Gabriella Zupi
Michèle Milella
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Publication Year: 2009
DOI: https://doi.org/10.1200/jco.2008.20.7977
Abstract:
Add to Library
Authors:
Georg Heß
Raoul Herbrecht
Jorge Romaguera
Gregor Verhoef
Michael Crump
Christian Gisselbrecht
Anna Laurell
Fritz Offner
Andrew Strahs
Anna Berkenblit
Orysia Hanushevsky
Jill S. Clancy
Becker Hewes
Laurence Moore
Bertrand Coiffier
Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell Lymphoma
Publication Year: 2005
DOI: https://doi.org/10.1200/jco.2005.13.466
Abstract:
Add to Library
Authors:
Thomas E. Witzig
Susan M. Geyer
Irene M. Ghobrial
David J. Inwards
Rafaël Fonseca
Paul J. Kurtin
Stephen M. Ansell
Ronnie F. Luyun
Patrick J. Flynn
Roscoe F. Morton
Shaker R. Dakhil
Howard M. Gross
Scott H. Kaufmann
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
Publication Year: 2006
DOI: https://doi.org/10.1038/sj.bjc.6603419
Abstract:
Add to Library
Authors:
Ignacio Durán
Jeremy Kortmansky
DeeptiSingh Chalia
Hal W. Hirte
Walter Kocha
Glenwood D. Goss
Lyly Le
Amit M. Oza
Trudey Nicklee
Jcm Ho
Diana C. Birle
Gregory R. Pond
D Arboine
Janet Dancey
Sarit Aviel‐Ronen
Ming‐Sound Tsao
David W. Hedley
Lillian L. Siu
Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer
Publication Year: 2005
DOI: https://doi.org/10.1200/jco.2005.66.130
Abstract:
Add to Library
Authors:
Stephen Chan
M. E. Scheulen
Justin Stebbing
K. Mross
Fátima Cardoso
Christian Dittrich
W. Eiermann
Dagmar Hess
Rudolph Morant
Semiglazov Vf
Markus Borner
Marc Salzberg
Valerijus Ostapenko
H. J. Illiger
Dirk Behringer
Nathalie Bardy‐Bouxin
Joseph Boni
Steven Kong
Maria Cincotta
Laurence Moore
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
Publication Year: 2016
DOI: https://doi.org/10.1016/s0140-6736(15)00667-4
Abstract:
Add to Library
Authors:
Martin Dreyling
Wojciech Jurczak
Mats Jerkeman
Rodrigo Santucci Silva
Chiara Rusconi
Marek Trněný
Fritz Offner
Dolores Caballero
Cristina João
Mathias Witzens‐Harig
Georg Heß
Isabelle Bence‐Bruckler
Seok‐Goo Cho
John Bothos
Jeffrey L. Goldberg
Christopher Enny
Shana Traina
Sriram Balasubramanian
Nibedita Bandyopadhyay
Steven Sun
Jessica Vermeulen
Aleksandra Rizo
Simon Rule
Temsirolimus, an Inhibitor of Mammalian Target of Rapamycin
Publication Year: 2008
DOI: https://doi.org/10.1158/1078-0432.ccr-07-4719
Abstract:
Add to Library
Authors:
Randomized Phase III Trial of Temsirolimus Versus Sorafenib As Second-Line Therapy After Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Publication Year: 2014
DOI: https://doi.org/10.1200/jco.2013.50.3961
Abstract:
Add to Library
Authors:
Thomas Powles
Bernard Escudier
Emilio Esteban
Georg A. Bjarnason
Ho Yeong Lim
K. Pittman
P. Senico
Andreas G. Niethammer
Dongrui R. Lu
Hariharan Subramanian
Robert J. Motzer
Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus
Publication Year: 2006
DOI: https://doi.org/10.1016/j.ejca.2006.03.015
Abstract:
Add to Library
Authors:
Ignacio Durán
L. Siu
Amit M. Oza
TaeBong Chung
J. Sturgeon
Carol Townsley
Gregory R. Pond
Lesley Seymour
Mina Cheraghi Niroumand
FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma
Publication Year: 2010
DOI: https://doi.org/10.1634/theoncologist.2009-0178
Abstract:
Add to Library
Authors:
Virginia E. Kwitkowski
Tatiana M. Prowell
Amna Ibrahim
Ann T. Farrell
Robert Justice
Shan Sun Mitchell
Rajeshwari Sridhara
Richard Pazdur
Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma
Publication Year: 2007
DOI: https://doi.org/10.1016/j.eururo.2007.11.037
Abstract:
Add to Library
Authors:
Naeem Bhojani
Claudio Jeldres
Jean‐Jacques Patard
Paul Perrotte
Nazareno Suardi
Georg C. Hutterer
François Patenaude
Stéphane Oudard
Pierre I. Karakiewicz
Low‐dose, single‐agent temsirolimus for relapsed mantle cell lymphoma
Publication Year: 2008
DOI: https://doi.org/10.1002/cncr.23580
Abstract:
Add to Library
Authors:
Stephen M. Ansell
David J. Inwards
Kendrith M. Rowland
Patrick J. Flynn
Roscoe F. Morton
Dennis F. Moore
Scott H. Kaufmann
Irene M. Ghobrial
Paul J. Kurtin
Matthew J. Maurer
Christine Allmer
Thomas E. Witzig
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
Publication Year: 2011
DOI: https://doi.org/10.1200/jco.2010.34.1578
Abstract:
Add to Library
Authors:
Amit M. Oza
Laurie Elit
Ming‐Sound Tsao
Suzanne Kamel‐Reid
Jim Biagi
Diane Provencher
Walter H. Gotlieb
Paul Hoskins
Prafull Ghatage
Katia Tonkin
Helen Mackay
J Mazurka
Joana Sederias
Percy Ivy
Janet Dancey
Elizabeth Eisenhauer
Found 16720 results in 0.051 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"